Arachnoid hyperplasia in optic nerve glioma.

Arachnoid hyperplasia in optic nerve glioma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Arachnoid hyperplasia in optic nerve glioma. Abstract Text:

Arachnoid hyperplasia in optic nerve glioma. Publishing Authors By Initials

For similar nervous system diseases: cranial nerve diseases: optic nerve diseases research abstracts see: nervous system diseases: cranial nerve diseases: optic nerve diseases research

PUBMED ID PMID:

MEDLINE DATE:

Arachnoid hyperplasia in optic nerve glioma. Journal Published:

PUBLICATION TYPE: Letter

Journal: The British journal of ophthalmology

VOLUME: 64

Page Numbers: 638-40

Journal Abbreviation: Br J Ophthalmol

ISSN: 0007-1161

DAY: 28

MONTH: Aug

YEAR: 1980

Arachnoid hyperplasia in optic nerve glioma. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 421041

Arachnoid hyperplasia in optic nerve glioma. Keywords Mesh Terms:

KEYWORDS: Optic Nerve Diseases

MESH TERMS: pathology

Chemical & Substance for Abstract: Arachnoid hyperplasia in optic nerve glioma. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Arachnoid hyperplasia in optic nerve glioma.

AFFILIATION:

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br J Ophthalmol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Arachnoid hyperplasia in optic nerve glioma Related Publications

• A good death for residents of long-term care: family members speak.
• A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance.
• Addressing immunization barriers, benefits, and risks.
• CYP2B6 983T>C polymorphism is prevalent in West Africa but absent in Papua New Guinea: implications for HIV/AIDS treatment.
• Challenges in replicating interventions.
• Childhood emotional, physical, and sexual abuse, and diagnoses of depressive and anxiety disorders in adult psychiatric outpatients.
• Dementia care mapping as a research tool.
• Does comorbid Social Anxiety Disorder impact the clinical presentation of principal Major Depressive Disorder?
• Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling.
• Formation of cartilage matrix proteins by BMP-transfected murine mesenchymal stem cells encapsulated in a novel class of alginates.
• Fundus changes in central retinal artery occlusion.
• HLA-DR4 in families with autism.
• Identification of plasma antifibrin/fibrinogen antibodies in a patient with hemolytic uremic syndrome.
• Incipient nonarteritic anterior ischemic optic neuropathy.
• Infection in a leukemia patient.
• Longitudinal trends in antibiotic resistance in US nursing homes, 2000-2004.
• Malaria vector incrimination in three rural riverine villages in the Brazilian Amazon.
• Microsatellite polymorphism within pfcrt provides evidence of continuing evolution of chloroquine-resistant alleles in Papua New Guinea.
• Nonarteritic anterior ischemic optic neuropathy and tobacco smoking.
• Physician communication with family caregivers of long-term care residents at the end of life.
• Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations.
• Psychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipation.
• Pyrones to pyrans: enantioselective radical additions to acyloxy pyrones.
• Recent changes in influenza vaccination recommendations, 2007.
• Search for electron neutrino appearance at the Delta m2 approximately 1 eV2 scale.
• Testing the waters.
• The effects of cumulative risks and promotive factors on urban adolescent alcohol and other drug use: a longitudinal study of resiliency.
• Theophylline improves esophageal chest pain--a randomized, placebo-controlled study.
• Time difference scanning gel chromatography: Computer simulations.
• mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets.